Press

Vancouver, B.C. March 7, 2022 – Treatment.com International Inc. (“Treatment” or the “Company”) (CSE: TRUE; OTC: TREIF; FFA 939), a global healthcare technology company that has developed a next generation…

VANCOUVER, British Columbia, Feb. 17, 2022 (GLOBE NEWSWIRE) — Treatment.com International Inc. (“Treatment” or the “Company”) (CSE: TRUE; OTC: TREIF; FFA 939) is a global healthcare technology company that has…

Vancouver, B.C. January 24th, 2022 – Treatment.com International Inc. (“Treatment” or the “Company”) (CSE: TRUE; OTC: TREIF; FFA 939) is a global healthcare technology company that has developed a next-generation…

Treatment.com International Inc. (“Treatment” or the “Company”) (CSE: TRUE), (OTC: TREIF), a healthcare AI technology company, has entered into a research project agreement with the University of Minnesota to add…

Treatment.com International Inc. (“Treatment or the (“Company”) (CSE: TRUE • OTC: TREIF • 939.F) is a healthcare technology company with a passion for supporting consumers and health care providers globally…

NOTICE IS HEREBY GIVEN that the Annual General and Special Meeting (the “Meeting”) of the shareholders of Treatment.com International Inc. (the “Company”) will be held virtually on Tuesday, December 28,…

Valuethemarkets.com has reported that Treatment.com International is helping to take the multi-billion-dollar global healthcare market into the digital age, through effective use of hyper-personalization and big data. With the recent…

Treatment.com International Inc. (“Treatment” or the “Company”) (CSE: TRUE; OTC: TREIF; FFA 939) is a global healthcare technology company that has developed a next-generation AI platform to help clinicians and…

Treatment.com International Inc. (“Treatment” or the “Company”) (CSE: TRUE), (OTC: TREIF), a healthcare AI technology company, has expanded the reach of its Global Library of Medicine (GLM) by adding more…